BioLife Solutions
BLFS
187 hedge funds and large institutions have $952M invested in BioLife Solutions in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 71 increasing their positions, 54 reducing their positions, and 29 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 54
14% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 29
1.62% more ownership
Funds ownership: 101.66% → 103.28% (+1.6%)
0% more funds holding
Funds holding: 187 → 187 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $1.18B → $952M (-$232M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$29.3M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$14M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$8.46M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$5.3M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$4.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$35M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$12M |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$9.15M |
| 4 |
DM
Deerfield Management
New York
|
-$2.91M |
| 5 |
Morgan Stanley
New York
|
-$2.01M |
BLFS Hedge Fund Activity: Q1 2026 in Review
187 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2026, worth a combined $952M — down 20% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BLFS positions and 29 closed out — a net gain of 4 holders — while 71 added to existing stakes and 54 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $29.3M. The largest seller was Invesco, cutting an estimated $35M.
- 187 institutional investors held BioLife Solutions (BLFS) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $952M of BioLife Solutions stock for Q1 2026, down 20% quarter-over-quarter.
- 33 funds opened new BioLife Solutions positions in Q1 2026 and 29 closed out, a net change of +4 holders.
- The largest BioLife Solutions buyer in Q1 2026 was T. Rowe Price Investment Management, an estimated $29.3M added.
- The largest BioLife Solutions seller in Q1 2026 was Invesco, an estimated $35M sold.
Based on aggregated 13F filings for Q1 2026.